<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  

Dadun > Depósito Académico > Clínica Universidad de Navarra > Hematología y Hemoterapia > DA - CUN - Hematología y Hemoterapia - Artículos de revista >

Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis
Autor(es) : Rocha, E. (Eduardo)
Martinez-Gonzalez, M.A. (Miguel Ángel)
Montes, R. (Ramón)
Panizo, C. (Carlos)
Palabras clave : Hemorrhage/chemically induced
Heparin/standards/therapeutic use/toxicity
Heparin, Low-Molecular-Weight/standards/therapeutic use/toxicity
Fecha incorporación: 2000
Editorial : Ferrata Storti Foundation
Versión del editor: http://www.haematologica.org/content/85/9/935.long
ISSN: 0390-6078
Cita: Rocha E, Martinez-Gonzalez MA, Montes R, Panizo C. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica 2000 Sep;85(9):935-942.
We compared the efficacy and safety of low molecular weight heparins (LMWH) and unfractionated heparin (UFH) in the treatement of deep venous thrombosis (DVT). A comparison between two daily subcutaneous injections of LMWH against a single injection was also performed. DESIGN AND METHODS: The study was performed by a meta-analysis. Clot improvement in venography, recurrency, total mortality and major hemorrhages were assessed in 4,472 patients with DVT from 21 studies treated with subcutaneous LMWH or UFH. RESULTS: An improvement in clot reduction (odds ratio 0.73, 95% confidence interval 0.59 to 0.90, p = 0.004), a decrease in total mortality (0. 68, 0.50 to 0.91, p = 0.012) and a lower incidence of hemorrhage (0. 65, 0.43 to 0.98, p = 0.047) were observed in LMWH treated patients. There were no differences in recurrences (0.78, 0.59 to 1.04, p = 0. 10). A single dose of LMWH was better than two in reducing major bleeding (c2 = 4.99, p = 0.025); however, the two dose regimen was more effective in clot reduction (c2 = 8.56, p = 0.004). INTERPRETATION AND CONCLUSIONS: LMWH is superior to UFH in terms of safety and efficacy. A single daily dose of LMWH dose is a suitable therapeutic regimen and could facilitate the outpatient treatment of venous thromboembolism.
Enlace permanente: http://hdl.handle.net/10171/23480
Aparece en las colecciones: DA - Medicina - MPSP -Artículos de revista
DA - CUN - Hematología y Hemoterapia - Artículos de revista

Ficheros en este registro:
Fichero:  Haematologica 2000 .935.full.pdf
Tamaño:  145,9 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.